BIRC5 and central nervous system cancer: Other studies have identified that high-grade astrocytomas and gliomas expressing both nuclear and cytoplasmic survivin exhibited a poorer survival rate than individuals with tumors expressing only nuclear or cytoplasmic survivin [46].